Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析

◆英語タイトル:Immunomedics Inc (IMMU) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0434
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Immunomedics Inc (IMMU) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops candidates based on its proprietary technologies namely, ADC Linker technology and Dock-And-Lock platform. Its lead product candidate Sacituzumab govitecan (IMMU-132) received breakthrough therapy designation from the US FDA for the treatment of patients with metastatic triple-negative breast cancer and metastatic solid cancers. Immunomedics’ other lead product candidates include Labetuzumab Govitecan (IMMU-130) and Epratuzumab. It also has other product candidates that target solid tumors, hematologic malignancies and other diseases, in various stages of clinical and pre-clinical development. The company also manufactures and commercializes diagnostic imaging product. Immunomedics is headquartered in Morris Plains, New Jersey, the US.

Immunomedics Inc Key Recent Developments

Oct 30,2019: Immunomedics reports third quarter 2019 results and provides corporate update
Aug 07,2019: Immunomedics reports second quarter 2019 results and provides corporate update
May 09,2019: Immunomedics reports first quarter 2019 results and provides corporate update
Apr 29,2019: Immunomedics announces departure of Chief Medical Officer
Mar 07,2019: Immunomedics appoints Barbara G. Duncan to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Immunomedics Inc – Key Facts
Immunomedics Inc – Key Employees
Immunomedics Inc – Key Employee Biographies
Immunomedics Inc – Major Products and Services
Immunomedics Inc – History
Immunomedics Inc – Company Statement
Immunomedics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Immunomedics Inc – Business Description
Immunomedics Inc – Corporate Strategy
Immunomedics Inc – SWOT Analysis
SWOT Analysis – Overview
Immunomedics Inc – Strengths
Immunomedics Inc – Weaknesses
Immunomedics Inc – Opportunities
Immunomedics Inc – Threats
Immunomedics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Immunomedics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 30, 2019: Immunomedics reports third quarter 2019 results and provides corporate update
Aug 07, 2019: Immunomedics reports second quarter 2019 results and provides corporate update
May 09, 2019: Immunomedics reports first quarter 2019 results and provides corporate update
Apr 29, 2019: Immunomedics announces departure of Chief Medical Officer
Mar 07, 2019: Immunomedics appoints Barbara G. Duncan to Board of Directors
Feb 25, 2019: Immunomedics reports results for period ended December 31, 2018, strengthens board And announces senior leadership changes
Feb 24, 2019: Immunomedics 24 hour deadline alert: approximately 24 hours remain; Claimsfiler reminds investors with losses in excess of $100,000 of deadline in class action lawsuit against immunomedics – IMMU
Feb 20, 2019: FDA Issues Form 483 to Immunomedics Inc
Nov 07, 2018: Immunomedics announces first quarter fiscal 2019 results and provides corporate update
Aug 23, 2018: Immunomedics announces fourth quarter and fiscal year 2018 results and provides corporate update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Immunomedics Inc, Key Facts
Immunomedics Inc, Key Employees
Immunomedics Inc, Key Employee Biographies
Immunomedics Inc, Major Products and Services
Immunomedics Inc, History
Immunomedics Inc, Subsidiaries
Immunomedics Inc, Key Competitors
Immunomedics Inc, Ratios based on current share price
Immunomedics Inc, Annual Ratios
Immunomedics Inc, Annual Ratios (Cont...1)
Immunomedics Inc, Interim Ratios
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Immunomedics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Immunomedics Inc, Performance Chart (2014 - 2018)
Immunomedics Inc, Ratio Charts
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Immunomedics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Immunomedics Inc (IMMU):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interfor Corp:企業の戦略・SWOT・財務情報
    Interfor Corp - Strategy, SWOT and Corporate Finance Report Summary Interfor Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sunesis Pharmaceuticals Inc (SNSS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's Vosaroxin is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). …
  • Tadano Ltd:企業の戦略・SWOT・財務分析
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cinnabon LLC:企業の戦略・SWOT・財務情報
    Cinnabon LLC - Strategy, SWOT and Corporate Finance Report Summary Cinnabon LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WABCO Holdings Inc.:企業の戦略・SWOT・財務情報
    WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary WABCO Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • eResearchTechnology Inc:企業の戦略的SWOT分析
    eResearchTechnology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Amcor Ltd:戦略・SWOT・企業財務分析
    Amcor Ltd - Strategy, SWOT and Corporate Finance Report Summary Amcor Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • New York Power Authority:電力:M&Aディール及び事業提携情報
    Summary New York Power Authority (NYPA) is a state-owned power organization. It generates electricity, and transmits and sells that on wholesale basis. The authority produces the electricity using hydro, gas, and oil sources. Through long-term electricity supply agreement with Astoria Energy II LLC, …
  • Rajesh Exports Limited:企業の戦略・SWOT・財務情報
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Midmac Contracting Co. W.L.L.:企業の戦略・SWOT・財務情報
    Midmac Contracting Co. W.L.L. - Strategy, SWOT and Corporate Finance Report Summary Midmac Contracting Co. W.L.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • SM Energy Co (SM):企業の財務・戦略的SWOT分析
    SM Energy Co (SM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • China National Petroleum Corporation:企業の戦略・SWOT・財務情報
    China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Sykes Enterprises, Incorporated:企業の戦略・SWOT・財務情報
    Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Sykes Enterprises, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • El Gezirah Hotels & Tourism Co. S.A.E.:企業の戦略・SWOT・財務分析
    El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report Summary El Gezirah Hotels & Tourism Co. S.A.E. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • JD Sports Fashion Plc:戦略・SWOT・企業財務分析
    JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report Summary JD Sports Fashion Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Zhuhai Holdings Investment Group Co Ltd
    Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zhuhai Holdings Investment Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • G4S plc:企業の戦略・SWOT・財務分析
    G4S plc - Strategy, SWOT and Corporate Finance Report Summary G4S plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Exchange Income Corporation:企業の戦略・SWOT・財務情報
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • DISH Network Corp (DISH):企業の財務・戦略的SWOT分析
    DISH Network Corp (DISH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆